FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2278876196> ?p ?o ?g. }

• W2278876196 abstract "PURPOSE To determine, in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) on interferon alfa (IFNalpha), whether combining pretreatment characteristics and early response profiles would distinguish patients with differential benefits that would allow better decisions on subsequent therapy. PATIENTS AND METHODS A total of 274 patients treated from 1982 through 1990 with IFNalpha regimens were analyzed. A second group of 137 patients treated with IFNalpha and low-dose cytarabine (ara-C) between 1990 and 1994 was later used to confirm the guidelines derived from the original study group analysis. Patients' pretreatment factors and response to IFNalpha therapy at 3, 6, and 12 months were analyzed in relation to subsequent achievement of major cytogenetic response. After univariate analysis of prognostic factors, a multivariate analysis selected, at 6 months, independent pretreatment factors that added to the response status in predicting subsequent outcome. The results were then applied at the 3- and 12-month periods and confirmed in the subsequent population. RESULTS Response to IFNalpha therapy at 3, 6, and 12 months was a significant predictor of later major cytogenetic response. The presence of splenomegaly > or = 5 cm below the costal margin (BCM) or thrombocytosis > or = 700 x 10(9)/L pretreatment added significant independent prediction to response. At 6 months, patients with a partial hematologic response (PHR) or resistant disease had a less than 10% chance of achieving a later major cytogenetic response, as were those in complete hematologic response (CHR) and who had pretreatment splenomegaly and thrombocytosis. Applying the model at 3 months showed that only patients with < or = PHR and pretreatment splenomegaly or thrombocytosis at 3 months had such a low major cytogenetic response rate. Finally, at 12 months, patients with CHR still had a 15% to 25% chance of having a major cytogenetic response later if they did not have pretreatment splenomegaly and thrombocytosis. CONCLUSION This analysis allows better selection of patients with Ph-positive CML on IFNalpha therapy for continuation of IFNalpha versus changing therapy early in the course of CML. For treatment programs that choose to change patients to other investigational therapies (eg, intensive chemotherapy and/or autologous stem-cell transplantation [SCT]), baseline outcome expectations are provided for patients continued on IFNalpha therapy, against which the results of new approaches can be compared." @default.
• W2278876196 created "2016-06-24" @default.
• W2278876196 creator A5006104041 @default.
• W2278876196 creator A5011529063 @default.
• W2278876196 creator A5016607292 @default.
• W2278876196 creator A5027575595 @default.
• W2278876196 creator A5030171128 @default.
• W2278876196 creator A5038107984 @default.
• W2278876196 creator A5049158191 @default.
• W2278876196 creator A5073798523 @default.
• W2278876196 creator A5090435894 @default.
• W2278876196 date "1998-03-01" @default.
• W2278876196 modified "2023-10-12" @default.
• W2278876196 title "Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia." @default.
• W2278876196 cites W1498708301 @default.
• W2278876196 cites W1799579309 @default.
• W2278876196 cites W188630774 @default.
• W2278876196 cites W1893871329 @default.
• W2278876196 cites W1917754692 @default.
• W2278876196 cites W1989333836 @default.
• W2278876196 cites W2034608128 @default.
• W2278876196 cites W2038990138 @default.
• W2278876196 cites W2058190985 @default.
• W2278876196 cites W2276472705 @default.
• W2278876196 cites W2337803710 @default.
• W2278876196 cites W2416239254 @default.
• W2278876196 cites W977069352 @default.
• W2278876196 doi "https://doi.org/10.1200/jco.1998.16.3.882" @default.
• W2278876196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9508169" @default.
• W2278876196 hasPublicationYear "1998" @default.
• W2278876196 type Work @default.
• W2278876196 sameAs 2278876196 @default.
• W2278876196 citedByCount "15" @default.
• W2278876196 crossrefType "journal-article" @default.
• W2278876196 hasAuthorship W2278876196A5006104041 @default.
• W2278876196 hasAuthorship W2278876196A5011529063 @default.
• W2278876196 hasAuthorship W2278876196A5016607292 @default.
• W2278876196 hasAuthorship W2278876196A5027575595 @default.
• W2278876196 hasAuthorship W2278876196A5030171128 @default.
• W2278876196 hasAuthorship W2278876196A5038107984 @default.
• W2278876196 hasAuthorship W2278876196A5049158191 @default.
• W2278876196 hasAuthorship W2278876196A5073798523 @default.
• W2278876196 hasAuthorship W2278876196A5090435894 @default.
• W2278876196 hasConcept C126322002 @default.
• W2278876196 hasConcept C143998085 @default.
• W2278876196 hasConcept C144301174 @default.
• W2278876196 hasConcept C203014093 @default.
• W2278876196 hasConcept C2776178377 @default.
• W2278876196 hasConcept C2776694085 @default.
• W2278876196 hasConcept C2776960273 @default.
• W2278876196 hasConcept C2778461978 @default.
• W2278876196 hasConcept C2779316324 @default.
• W2278876196 hasConcept C2779788118 @default.
• W2278876196 hasConcept C2781228144 @default.
• W2278876196 hasConcept C2908647359 @default.
• W2278876196 hasConcept C2909179924 @default.
• W2278876196 hasConcept C38180746 @default.
• W2278876196 hasConcept C71924100 @default.
• W2278876196 hasConcept C89560881 @default.
• W2278876196 hasConcept C90924648 @default.
• W2278876196 hasConcept C99454951 @default.
• W2278876196 hasConceptScore W2278876196C126322002 @default.
• W2278876196 hasConceptScore W2278876196C143998085 @default.
• W2278876196 hasConceptScore W2278876196C144301174 @default.
• W2278876196 hasConceptScore W2278876196C203014093 @default.
• W2278876196 hasConceptScore W2278876196C2776178377 @default.
• W2278876196 hasConceptScore W2278876196C2776694085 @default.
• W2278876196 hasConceptScore W2278876196C2776960273 @default.
• W2278876196 hasConceptScore W2278876196C2778461978 @default.
• W2278876196 hasConceptScore W2278876196C2779316324 @default.
• W2278876196 hasConceptScore W2278876196C2779788118 @default.
• W2278876196 hasConceptScore W2278876196C2781228144 @default.
• W2278876196 hasConceptScore W2278876196C2908647359 @default.
• W2278876196 hasConceptScore W2278876196C2909179924 @default.
• W2278876196 hasConceptScore W2278876196C38180746 @default.
• W2278876196 hasConceptScore W2278876196C71924100 @default.
• W2278876196 hasConceptScore W2278876196C89560881 @default.
• W2278876196 hasConceptScore W2278876196C90924648 @default.
• W2278876196 hasConceptScore W2278876196C99454951 @default.
• W2278876196 hasLocation W22788761961 @default.
• W2278876196 hasLocation W22788761962 @default.
• W2278876196 hasOpenAccess W2278876196 @default.
• W2278876196 hasPrimaryLocation W22788761961 @default.
• W2278876196 hasRelatedWork W1978860220 @default.
• W2278876196 hasRelatedWork W2068182812 @default.
• W2278876196 hasRelatedWork W2126479366 @default.
• W2278876196 hasRelatedWork W2278876196 @default.
• W2278876196 hasRelatedWork W2410402004 @default.
• W2278876196 hasRelatedWork W2411769263 @default.
• W2278876196 hasRelatedWork W2412968976 @default.
• W2278876196 hasRelatedWork W2413371227 @default.
• W2278876196 hasRelatedWork W2415504479 @default.
• W2278876196 hasRelatedWork W862678944 @default.
• W2278876196 isParatext "false" @default.
• W2278876196 isRetracted "false" @default.
• W2278876196 magId "2278876196" @default.
• W2278876196 workType "article" @default.